Genetic variability related to serum uric acid concentration and risk of Parkinson's disease

Movement Disorders

Volumn 28, Issue 12, 2013, Pages 1737-1740

  González Aramburu, Isabel ^a   Sánchez Juan, Pascual ^a,b   Jesús, Silvia ^c   Gorostidi, Ana ^b,d,e   Fernández Juan, Eduardo ^a   Carrillo, Fátima ^c   Sierra, María ^a,b   Gómez Garre, Pilar ^b,c   Cáceres Redondo, María T ^c   Berciano, José ^a,b   Ruiz Martínez, Javier ^b,d,e   Combarros, Onofre ^a,b   Mir, Pablo ^b,c   Infante, Jon ^a,b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^e HOSPITAL DONOSTIA   (Spain)

Author keywords

Genetics; Parkinson's disease; Uric acid

Indexed keywords

MEMBRANE PROTEIN; SLC22A11 PROTEIN; SLC22A12 PROTEIN; SODIUM PHOSPHATE COTRANSPORTER 1; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGED; ALLELE; ARTICLE; DISEASE COURSE; FEMALE; GENETIC ANALYSIS; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; STUDENT T TEST; URIC ACID BLOOD LEVEL;

GENETICS; PARKINSON'S DISEASE; URIC ACID;

AGED; ALLELES; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; URIC ACID;

EID: 84886412353     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25507     Document Type: Article

References (17)

1. Cipriani S, Desjardins CA, Burdett TC, Xu Y, Xu K, Schwarzschild MA. Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease. PLoS One 2012;7:e37331.
2. Gong L, Zhang QL, Zhang N, et al. Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway. J Neurochem 2012;123:876-885.
3. Davis JW, Grandinetti A, Waslien CI, Ross GW, White LR, Morens DM. Observations of serum uric acid levels and the risk of idiopathic Parkinson's disease. Am J Epidemiol 1996;144:480-484.
4. Ascherio A, LeWitt PA, Xu K, et al.;Parkinson Study Group DATATOP Investigators. Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol 2009;66:1460-1468.
5. de Lau LM, Koudstaal PJ, Hofman A, Breteler MM. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol 2005;58:797-800.
6. Jesús S, Pérez I, Cáceres-Redondo MT, et al. Low serum uric acid concentration in Parkinson's disease in Southern Spain. Eur J Neurol 2013;20:208-210.
7. Yang Q, Guo CY, Cupples LA, Levy D, Wilson PW, Fox CS. Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Metabolism 2005;54:1435-1441.
8. Kolz M, Johnson T, Sanna S, et al. Meta-analysis of 28, 141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009;5:e1000504.
9. van der Harst P, Bakker SJ, de Boer RA, et al. Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet 2010;19:387-395.
10. Yang Q, Köttgen A, Dehghan A, et al. Multiple genetic loci influence serum urate and their relationship with gout and cardiovascular risk factors. Circ Cardiovasc Genet 2010;3:523-530.
11. Gunjaca G, Boban M, Pehlić M, et al. Predictive value of 8 genetic loci for serum uric acid concentration. Croat Med J 2010;51:23-31.
12. Lawlor DA, Harbord RM, Sterne JA, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008;27:1133-1163.
13. Alonso A, Rodríguez LA, Logroscino G, Hernán MA. Gout and risk of Parkinson disease: a prospective study. Neurology 2007;69:1696-1700.
14. O'Reilly EJ, Gao X, Weisskopf MG, et al. Plasma urate and Parkinson's disease in women. Am J Epidemiol 2010;172:666-670.
15. Nilsen J, Brinton RD. Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord 2004;3:297-313.
16. Wang K, Li M, Bucan M. Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 2007;81:1278-1283.
17. Zhong H, Yang X, Kaplan LM, Molony C, Schadt EE. Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am J Hum Genet 2010;86:581-591.